Sign in

CIK 0000318154

  • Large accelerated filer
Ticker
AMGN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
953540776
Phone
+1 805-447-1000
Business address
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA, 91320
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-03-10 SUGAR RONALD D Director Exercise or conversion · Nqso (Right to Buy) −1,000 2,000
2021-03-02 Santos Esteban EVP, Operations Grant or award +8,725 53,251
2021-03-02 REESE DAVID M EVP, Research and Development Grant or award +2,803 43,715
2021-03-02 Piacquad David SVP, Business Development Grant or award +2,648 45,504
2021-03-02 Louie Linda H. VP, Finance & CAO Grant or award +467 8,113
2021-03-02 Johnston Lori A EVP, HR Grant or award +5,608 37,682
2021-03-02 Grygiel Nancy A. SVP & CCO Grant or award +1,245 12,401
2021-03-02 Graham Jonathan P EVP, Gen. Counsel & Secy. Grant or award +8,725 48,670
2021-03-02 Gordon Murdo EVP Global Commercial Ops Grant or award +17,989 50,159
2021-03-02 Bradway Robert A Chairman, CEO and President Grant or award +38,953 609,806
2021-02-18 Bradway Robert A Chairman, CEO and President Exercise or conversion +73,500 $54.69 $4.0M 618,380
2021-02-18 Bradway Robert A Chairman, CEO and President Shares withheld for taxes −47,527 $235.61 $11.2M 570,853
2021-02-18 Bradway Robert A Chairman, CEO and President Exercise or conversion · Nqso (Right to Buy) −73,500 0
2021-02-16 REESE DAVID M EVP, Research and Development Exercise or conversion +2,300 $54.69 $126K 42,059
2021-02-16 REESE DAVID M EVP, Research and Development Shares withheld for taxes −1,147 $237.21 $272K 40,912
2021-02-16 REESE DAVID M EVP, Research and Development Exercise or conversion · Nqso (Right to Buy) −2,300 0
2021-02-10 SUGAR RONALD D Director Exercise or conversion +1,000 $71.64 $72K 16,805
2021-02-10 SUGAR RONALD D Director Sale −1,000 $238.40 $238K 15,805
2021-02-10 SUGAR RONALD D Director Exercise or conversion · Nqso (Right to Buy) −1,000 3,000
2021-02-08 Williams R Sanders Director Sale −250 $237.99 $59K 4,659

Page 34 of 35 · 698 trades